Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10355-10361
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10355
Figure 1
Figure 1 The result of changes in prothrombin time (PT) and activated partial thromboplastin time (APTT), fibrinogen (FBG) and FBG degradation products (FDPs) with days during treatment. A: PT and APTT; B: FBG and FBG degradation products. Indicators above the upper limit are assigned as a maximum value, whereas those below the lower limit are assigned as a minimum value.